V-Square Quantitative Management’s Quest Diagnostics DGX Stock Holding History

V-Square Quantitative Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$869K	Sell	4,098 -178	-4%	-$34.9K	0.08%	215
2026 Q1	$838K	Buy	4,276 +742	+21%	+$144K	0.09%	198
2025 Q4	$613K	Buy	+3,534	New	+$644K	0.06%	257
2025 Q3	–	Sell	-3,463	Closed	-$622K	–	269
2025 Q2	$622K	Buy	3,463 +291	+9%	+$50.5K	0.08%	250
2025 Q1	$537K	Buy	3,172 +102	+3%	+$16.8K	0.08%	279
2024 Q4	$463K	Sell	3,070 -176	-5%	-$27.4K	0.07%	306
2024 Q3	$504K	Buy	3,246 +5	+0.2%	+$747	0.07%	291
2024 Q2	$444K	Buy	3,241 +127	+4%	+$17.4K	0.07%	277
2024 Q1	$415K	Buy	3,114 +456	+17%	+$59.2K	0.06%	313
2023 Q4	$366K	Buy	2,658 +511	+24%	+$67.2K	0.06%	279
2023 Q3	$262K	Buy	2,147 +1,443	+205%	+$192K	0.12%	237
2023 Q2	$99K	Buy	+704	New	+$97.1K	0.07%	224

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

V-Square Quantitative Management's DGX Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Quest Diagnostics (DGX) stake by 4.2% in Q2 2026, selling an estimated $34.9K and leaving 4,098 shares worth $869K. The position accounts for 0.08% of the portfolio, ranked #215.

V-Square Quantitative Management first reported a position in DGX in Q2 2023 and has held it in 12 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

V-Square Quantitative Management held 4,098 shares of Quest Diagnostics worth $869K as of Q2 2026.
V-Square Quantitative Management sold 178 Quest Diagnostics shares in Q2 2026, an estimated $34.9K.
Quest Diagnostics made up 0.08% of V-Square Quantitative Management's portfolio in Q2 2026, its #215 holding.
V-Square Quantitative Management first reported a position in Quest Diagnostics in Q2 2023 and has held it in 12 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.